mirage

Relevance of loss of heterozigosity in chromosome 3p in non small cell lung carcinoma as prognostic factor

Repositorio ABACUS/Manakin

Mostrar el registro sencillo del ítem

dc.contributor.author Maestro, María Luisa
dc.contributor.author Izquierdo, Luis Ángel
dc.contributor.author Sánchez-Pernaute, Andrés
dc.contributor.author Sanz Casla, María Teresa
dc.contributor.author González, Sonia
dc.contributor.author Torres, Antonio José
dc.contributor.author Barco, Victoria del
dc.contributor.author Autrán Gómez, Ana María
dc.contributor.author Pérez Aguirre, Elia
dc.contributor.author Balibrea, Jose Luis
dc.date.accessioned 2016-10-20T10:10:31Z
dc.date.available 2016-10-20T10:10:31Z
dc.date.issued 1999
dc.identifier.citation Maestro, M. L., Izquierdo, L., Sánchez-Pernaute, A., Sanz Casla, M. T., González, S., Torres, A., y Balibrea, J. L. (1999). Relevance of loss of heterozigosity in chromosome 3p in non small cell lung carcinoma as prognostic factor. Medicina Clínica, 112(14), 527-529. spa
dc.identifier.issn 00257753
dc.identifier.uri http://hdl.handle.net/11268/5884
dc.description.abstract Recent advances on carcinogenesis have led to the recognition of different patterns of behaviour of non-small cell lung cancers appart from those guided by the TNM staging system and the histologic subtype. The frequent genetic loss on chromosome 3p in all kinds of lung carcinoma leads to the suspect of the presence of a tumor suppresor gene located in that place. The aim of this work was to compare the different clinical features and evolution after treatment of the patients with non small cell lung carcinoma with and without loss of heterozigosity (LOH) on 3p. spa
dc.description.sponsorship SIN FINANCIACIÓN spa
dc.language.iso eng spa
dc.title Relevance of loss of heterozigosity in chromosome 3p in non small cell lung carcinoma as prognostic factor spa
dc.title.alternative Valor pronóstico de la pérdida de heterozigosidad en el cromosoma 3p en el carcinoma broncogénico no microcítico spa
dc.type article spa
dc.description.impact 0.811 JCR (1999) Q2, 39/110 Medicine, general & internal spa
dc.rights.accessRights closedAccess spa
dc.subject.uem Pulmones - Cáncer spa
dc.subject.uem Tumores spa
dc.subject.unesco Cáncer spa
dc.subject.unesco Medicina clínica spa
dc.description.filiation UEM spa
dc.peerreviewed Si spa


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem